MDR (EU) 2017/745 · IVDR (EU) 2017/746
Guides for medical device and IVD manufacturers preparing for, or maintaining, MDR and IVDR conformity.
MDR transition under Regulation (EU) 2023/607: 31 Dec 2027 for class III and implantable IIb, 31 Dec 2028 for the rest. The conditions, and what if you miss them.
The IVDR transition periods as extended by Regulation (EU) 2024/1860 for Class D, C, B and A sterile legacy IVDs, the QMS and Notified Body milestones, and the new duty to announce supply interruptions.
Checklist of what MDR technical documentation must contain: Annex II (description, labelling, design, GSPR, risk, verification and validation) and Annex III (PMS).
What post-market surveillance the MDR requires by device class: PMS plan, PMS report for Class I, PSUR frequency for Class IIa, IIb and III, and post-market clinical follow-up under Annex XIV Part B.
How the MDR Unique Device Identification system works: Basic UDI-DI vs UDI-DI vs UDI-PI, issuing entities, UDI carrier deadlines by class and where the Basic UDI-DI must appear.
How MDR Annex VIII Rule 11 classifies medical device software: decision-support software, monitoring software, the Class I fallback, and why most software is Class IIa or higher.